Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies

被引:241
作者
Singh, Nikhlesh K. [1 ]
Rao, Gadiparthi N. [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 71 S Manassas St Memphis, Memphis, TN 38163 USA
关键词
LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; PLATELET-TYPE; 12-LIPOXYGENASE; ARACHIDONIC-ACID METABOLITES; POLYUNSATURATED FATTY-ACIDS; ENZYMATIC LIPID OXIDATION; NITRIC-OXIDE; SELECTIVE INHIBITORS; 12/15; LIPOXYGENASE; ENDOTHELIAL-CELLS;
D O I
10.1016/j.plipres.2018.11.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
12/15-lipoxygenase (12/15-LOX) is an enzyme, which oxidizes polyunsaturated fatty acids, particularly omega-6 and-3 fatty acids, to generate a number of bioactive lipid metabolites. A large number of studies have revealed the importance of 12/15-LOX role in oxidative and inflammatory responses. The in vitro studies have demonstrated the ability of 12/15-LOX metabolites in the expression of various genes and production of cytokine related to inflammation and resolution of inflammation. The studies with the use of knockout and transgenic animals for 12/15-LOX have further shown its involvement in the pathogenesis of a variety of human diseases, including cardiovascular, renal, neurological and metabolic disorders. This review summarizes our current knowledge on the role of 12/15-LOX in inflammation and various human diseases.
引用
收藏
页码:28 / 45
页数:18
相关论文
共 303 条
[1]   Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old [J].
Adams, Kenneth F. ;
Schatzkin, Arthur ;
Harris, Tamara B. ;
Kipnis, Victor ;
Mouw, Traci ;
Ballard-Barbash, Rachel ;
Hollenbeck, Albert ;
Leitzmann, Michael F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) :763-778
[2]   Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins [J].
Adel, Susan ;
Karst, Felix ;
Gonzalez-Lafont, Angels ;
Pekarova, Maria ;
Saura, Patricia ;
Masgrau, Laura ;
Lluch, Jose M. ;
Stehling, Sabine ;
Horn, Thomas ;
Kuhn, Hartmut ;
Heydeck, Dagmar .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (30) :E4266-E4275
[3]   First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis [J].
Adili, Reheman ;
Tourdot, Benjamin E. ;
Mast, Katherine ;
Yeung, Jennifer ;
Freedman, John C. ;
Green, Abigail ;
Luci, Diane K. ;
Jadhav, Ajit ;
Simeonov, Anton ;
Maloney, David J. ;
Holman, Theodore R. ;
Holinstat, Michael .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (10) :1828-+
[4]   Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling [J].
Al-Huseini, Laith M. A. ;
Yeang, Han Xian Aw ;
Sethu, Swaminathan ;
Alhumeed, Naif ;
Hamdam, Junnat M. ;
Tingle, Yulia ;
Djouhri, Laiche ;
Kitteringham, Neil ;
Park, B. Kevin ;
Goldring, Christopher E. ;
Sathish, Jean G. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (31) :22281-22288
[5]  
Ander Bradley P, 2003, Exp Clin Cardiol, V8, P164
[6]   Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes [J].
Anderson, Sandra D. ;
Kippelen, Pascale .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (02) :225-235
[7]   Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice [J].
Anning, PB ;
Coles, B ;
Bermudez-Fajardo, A ;
Martin, PEM ;
Levison, BS ;
Hazen, SL ;
Funk, CD ;
Kühn, H ;
O'Donnell, VB .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (03) :653-662
[8]  
[Anonymous], BMJ BRIT MED J
[9]  
Archambault A. S., 2018, PLOS ONE, V13
[10]   The docosatriene Protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering [J].
Ariel, A ;
Li, PL ;
Wang, W ;
Tang, WX ;
Fredman, G ;
Hong, S ;
Gotlinger, KH ;
Serhan, CN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (52) :43079-43086